Christopher Britten
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Christopher Jonathan Britten is currently Non-Executive Chairman at Thalia Therapeutics Plc since 2023.
He is Head-Mergers & Acquisitions at Neuraxpharm UK Ltd. He is Operations Manager at Avenue Machinery Corp.
Formerly, Dr. Britten was Non-Executive Director at Phico Therapeutics Ltd. He was Director-Life Sciences at Deloitte LLP (United Kingdom).
He was Managing Director at Torreya Partners (Europe) LLP.
He was Global Head-Mergers & Acquisitions at Sandoz AG.
He was Head-Business Development at Sanofi Pasteur MSD SNC.
He was Senior Vice President-Merges & Acquisitions at Advanz Pharma Corp.
Ltd.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2024 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| THALIA THERAPEUTICS PLC | Président | 01/08/2023 |
Neuraxpharm UK Ltd.
Neuraxpharm UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for disorders affecting the central nervous system | Corporate Officer/Principal | - |
Avenue Machinery Corp.
Avenue Machinery Corp. Wholesale DistributorsDistribution Services Sells agriculture and construction equipment | Directeur des opérations | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ADVANZ PHARMA CORP. LIMITED | Corporate Officer/Principal | 02/01/2022 |
Deloitte LLP (United Kingdom)
Deloitte LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax services | Corporate Officer/Principal | - |
Sanofi Pasteur MSD SNC
Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Corporate Officer/Principal | - |
Torreya Partners (Europe) LLP
Torreya Partners (Europe) LLP Investment ManagersFinance Provides financial advisory services | Corporate Officer/Principal | - |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. BiotechnologyHealth Technology Develops novel platform technology designed to overcome antibacterial resistance | Health Technology |
Deloitte LLP (United Kingdom)
Deloitte LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax services | Commercial Services |
Sanofi Pasteur MSD SNC
Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Advanz Pharma Corp. Ltd.
Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Torreya Partners (Europe) LLP
Torreya Partners (Europe) LLP Investment ManagersFinance Provides financial advisory services | Finance |
N4 Pharma Plc
N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Neuraxpharm UK Ltd.
Neuraxpharm UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for disorders affecting the central nervous system | Health Technology |
Avenue Machinery Corp.
Avenue Machinery Corp. Wholesale DistributorsDistribution Services Sells agriculture and construction equipment | Distribution Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national